Market
Lanes are never summed. Equity is Form D filings and matched press rounds; awards and exits will have their own sources.
Health & bio: subsectors
6 subsectors, sized by amount sold · 90 days to 2026-10-04 · as of 2026-10-0416 rounds not yet in a sector
16 rounds not yet in a sector
- ▲ Rising
- Steady
- Leaning (80%)
- ▼ Falling
- Quiet
Coloured by subsector state, 28 days to 2026-10-03 vs prior 28; shaded when the change is clear at 90% confidence, palest when only at 80%.
Equity · amount sold
Capital by week
Dollars sold per filing week, round count under each bar · 4 weeks to 2026-10-04 · as of 2026-10-04Stage mix
Inferred stage · 90 days to 2026-10-04 · as of 2026-10-04- Pre-seed123 roundsPre-seed rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $157MAmount sold in original Pre-seed filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Seed383 roundsSeed rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $1.2BAmount sold in original Seed filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series A287 roundsSeries A rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $3.7BAmount sold in original Series A filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series B88 roundsSeries B rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $3.5BAmount sold in original Series B filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series C+84 roundsSeries C+ rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $28.8BAmount sold in original Series C+ filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Stage not inferred7 roundsStage not inferred rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $1.0BAmount sold in original Stage not inferred filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
Bar length is each stage’s share of the window’s rounds. Dollars of original filings only: an amendment’s restated amount counts in the map, not here. Stage is inferred from the amount sold, never stated on Form D; a stage named in a press release wins.
Where it landed
Which states the money was raised from, by the company's HQ · 90 days to 2026-10-04 · as of 2026-10-04- $0+
- $353M+
- $1.4B+
- $3.2B+
- $5.7B+
Mega-rounds shown separately (see the band above)
Rounds
Newest first · every row traces to a Form D on EDGAR or a matched press release · as of 2026-10-04| Company | Sector | Stage | Sold of offered | Filed | HQ | Exemption | Open roles | Hiring | Flags | |
|---|---|---|---|---|---|---|---|---|---|---|
| ApollomicsQuiet$10.0M of $10.0M · Series A · Health & bio · 506(b) · Foster City, CA · 2026-08-19 | Apollomics | Health & bio | Series A | $10.0M of $10.0MAmount sold of the amount offered on the filing of 2026-08-19 · as of 2026-10-04How this is computed → | 2026-08-19 | Foster City, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| AER TherapeuticsQuiet$3.0M of $3.0M · Seed · Health & bio · 506(b) · Research Triangle Park, NC · 2026-08-19 | AER Therapeutics | Health & bio | Seed | $3.0M of $3.0MAmount sold of the amount offered on the filing of 2026-08-19 · as of 2026-10-04How this is computed → | 2026-08-19 | Research Triangle Park, NC | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| GeorgiamuneHiring actively$92.7M of $132M · Series C+ · Health & bio · 506(b) · Gaithersburg, MD · 2026-08-17 | Georgiamune | Health & bio | Series C+ | $92.7M of $132MAmount sold of the amount offered on the filing of 2026-08-17 · as of 2026-10-04How this is computed → | 2026-08-17 | Gaithersburg, MD | 506(b) | 2The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| MBQ PharmaQuiet$1.5M · Seed · Health & bio · 506(b) · San Juan, PR · 2026-08-14 | MBQ Pharma | Health & bio | Seed | $1.5MAmount sold on the filing of 2026-08-14 · as of 2026-10-04How this is computed → | 2026-08-14 | San Juan, PR | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| AbcuroQuiet$39.4M of $177M · Series B · Health & bio · 506(b) · Newton, MA · 2026-08-13 | Abcuro | Health & bio | Series B | $39.4M of $177MAmount sold of the amount offered on the filing of 2026-08-13 · as of 2026-10-04How this is computed → | 2026-08-13 | Newton, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Hyku BiosciencesQuiet$8.6M of $8.6M · Series A · Health & bio · 506(b) · Concord, MA · 2026-08-13 | Hyku Biosciences | Health & bio | Series A | $8.6M of $8.6MAmount sold of the amount offered on the filing of 2026-08-13 · as of 2026-10-04How this is computed → | 2026-08-13 | Concord, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Auron TherapeuticsHiring actively$7.1M of $12.0M · Series A · Health & bio · 506(b) · Wellesley, MA · 2026-08-13AI-native | Auron TherapeuticsAI-native | Health & bio | Series A | $7.1M of $12.0MAmount sold of the amount offered on the filing of 2026-08-13 · as of 2026-10-04How this is computed → | 2026-08-13 | Wellesley, MA | 506(b) | 1The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | AI-native |
| Paterna BiosciencesQuiet$6.3M of $11.2M · Series A · Health & bio · 506(b) · Salt Lake City, UT · 2026-08-12 | Paterna Biosciences | Health & bio | Series A | $6.3M of $11.2MAmount sold of the amount offered on the filing of 2026-08-12 · as of 2026-10-04How this is computed → | 2026-08-12 | Salt Lake City, UT | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Prana TherapiesQuiet$40.2M of $40.2M · Series B · Health & bio · 506(b) · Encinitas, CA · 2026-08-10 | Prana Therapies | Health & bio | Series B | $40.2M of $40.2MAmount sold of the amount offered on the filing of 2026-08-10 · as of 2026-10-04How this is computed → | 2026-08-10 | Encinitas, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| PleoPharmaQuiet$5.5M of $15.0M · Seed · Health & bio · 506(b) · Phoenixville, PA · 2026-08-10 | PleoPharma | Health & bio | Seed | $5.5M of $15.0MAmount sold of the amount offered on the filing of 2026-08-10 · as of 2026-10-04How this is computed → | 2026-08-10 | Phoenixville, PA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| InSitu BiologicsQuiet$1.3M of $2.5M · Pre-seed · Health & bio · 506(b) · Oakdale, MN · 2026-08-10 | InSitu Biologics | Health & bio | Pre-seed | $1.3M of $2.5MAmount sold of the amount offered on the filing of 2026-08-10 · as of 2026-10-04How this is computed → | 2026-08-10 | Oakdale, MN | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Claris BioQuiet$55.7M of $121M · Series B · Health & bio · 506(b) · Half Moon Bay, CA · 2026-08-07AmendedUndersubscribed | Claris BioAmendedUndersubscribed | Health & bio | Series B | $55.7M of $121MAmount sold of the amount offered as of the filing of 2026-08-12 · as of 2026-10-04How this is computed → | 2026-08-07 | Half Moon Bay, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | AmendedUndersubscribed |
| BioGene TherapeuticsQuiet$3.0M of $3.0M · Seed · Health & bio · 506(b) · Austin, TX · 2026-08-07 | BioGene Therapeutics | Health & bio | Seed | $3.0M of $3.0MAmount sold of the amount offered on the filing of 2026-08-07 · as of 2026-10-04How this is computed → | 2026-08-07 | Austin, TX | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| BioGene Therapeutics: $3.0M of $3.0M · Seed · Health & bio · 506(b) · Austin, TX · 2026-08-06 | BioGene Therapeutics | Health & bio | Seed | $3.0M of $3.0MAmount sold of the amount offered on the filing of 2026-08-06 · as of 2026-10-04How this is computed → | 2026-08-06 | Austin, TX | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| BioGene Therapeutics: $4.5M of $4.5M · Seed · Health & bio · 506(b) · Austin, TX · 2026-07-23 | BioGene Therapeutics | Health & bio | Seed | $4.5M of $4.5MAmount sold of the amount offered on the filing of 2026-07-23 · as of 2026-10-04How this is computed → | 2026-07-23 | Austin, TX | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| AutomeraQuiet$1.0M of $7.0M · Pre-seed · Health & bio · 506(b) · Seattle, WA · 2026-08-07 | Automera | Health & bio | Pre-seed | $1.0M of $7.0MAmount sold of the amount offered on the filing of 2026-08-07 · as of 2026-10-04How this is computed → | 2026-08-07 | Seattle, WA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Integrated BiosciencesHiring actively$68.4M of $100M · Series C+ · Health & bio · 506(b) · Redwood City, CA · 2026-08-05AI-native | Integrated BiosciencesAI-native | Health & bio | Series C+ | $68.4M of $100MAmount sold of the amount offered on the filing of 2026-08-05 · as of 2026-10-04How this is computed → | 2026-08-05 | Redwood City, CA | 506(b) | 5The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | AI-native |
| Oncologic, Inc. / DEQuiet$26.7M of $26.7M · Series B · Health & bio · 506(b) · Orlando, FL · 2026-08-05 | Oncologic, Inc. / DE | Health & bio | Series B | $26.7M of $26.7MAmount sold of the amount offered on the filing of 2026-08-05 · as of 2026-10-04How this is computed → | 2026-08-05 | Orlando, FL | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Insignis TherapeuticsQuiet$6.0M of $8.5M · Seed · Health & bio · 506(b) · North Haven, CT · 2026-08-05 | Insignis Therapeutics | Health & bio | Seed | $6.0M of $8.5MAmount sold of the amount offered on the filing of 2026-08-05 · as of 2026-10-04How this is computed → | 2026-08-05 | North Haven, CT | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| TheradaptiveHiring actively$36.2M of $77.9M · Series B · Health & bio · 506(b) · Frederick, MD · 2026-08-04 | Theradaptive | Health & bio | Series B | $36.2M of $77.9MAmount sold of the amount offered on the filing of 2026-08-04 · as of 2026-10-04How this is computed → | 2026-08-04 | Frederick, MD | 506(b) | 1The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Ratio TherapeuticsQuiet$70.0M of $70.0M · Series C+ · Health & bio · 506(b) · Boston, MA · 2026-07-31 | Ratio Therapeutics | Health & bio | Series C+ | $70.0M of $70.0MAmount sold of the amount offered on the filing of 2026-07-31 · as of 2026-10-04How this is computed → | 2026-07-31 | Boston, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Mangrove Therapeutics Inc.Quiet$2.5M of $5.0M · Seed · Health & bio · 506(b) · Sacramento, CA · 2026-07-31 | Mangrove Therapeutics Inc. | Health & bio | Seed | $2.5M of $5.0MAmount sold of the amount offered on the filing of 2026-07-31 · as of 2026-10-04How this is computed → | 2026-07-31 | Sacramento, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| NextPoint TherapeuticsQuiet$33.7M of $48.7M · Series B · Health & bio · 506(b) · Cambridge, MA · 2026-07-30 | NextPoint Therapeutics | Health & bio | Series B | $33.7M of $48.7MAmount sold of the amount offered on the filing of 2026-07-30 · as of 2026-10-04How this is computed → | 2026-07-30 | Cambridge, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Biota Inc.Quiet$3.0M of $3.2M · Seed · Health & bio · 506(b) · Longmont, CO · 2026-07-30 | Biota Inc. | Health & bio | Seed | $3.0M of $3.2MAmount sold of the amount offered on the filing of 2026-07-30 · as of 2026-10-04How this is computed → | 2026-07-30 | Longmont, CO | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Accipiter BiosciencesQuiet$10.5M of $10.5M · Series A · Health & bio · 506(b) · Seattle, WA · 2026-07-28AI-native | Accipiter BiosciencesAI-native | Health & bio | Series A | $10.5M of $10.5MAmount sold of the amount offered on the filing of 2026-07-28 · as of 2026-10-04How this is computed → | 2026-07-28 | Seattle, WA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | AI-native |
| EstrigenixQuiet$1.0M of $2.0M · Pre-seed · Health & bio · 506(b) · Wauwatosa, WI · 2026-07-27 | Estrigenix | Health & bio | Pre-seed | $1.0M of $2.0MAmount sold of the amount offered on the filing of 2026-07-27 · as of 2026-10-04How this is computed → | 2026-07-27 | Wauwatosa, WI | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| HolobiomeQuiet$10.0M of $10.0M · Series A · Health & bio · 506(b) · Boston, MA · 2026-07-22 | Holobiome | Health & bio | Series A | $10.0M of $10.0MAmount sold of the amount offered on the filing of 2026-07-22 · as of 2026-10-04How this is computed → | 2026-07-22 | Boston, MA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| AdvanCellHiring actively$218M of $315M · Series C+ · Health & bio · 506(b) · Cambridge, MA · 2026-07-16 | AdvanCell | Health & bio | Series C+ | $218M of $315MAmount sold of the amount offered on the filing of 2026-07-16 · as of 2026-10-04How this is computed → | 2026-07-16 | Cambridge, MA | 506(b) | 10The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Sinopia BiosciencesHiring actively$2.8M of $4.3M · Seed · Health & bio · 506(b) · San Diego, CA · 2026-07-16 | Sinopia Biosciences | Health & bio | Seed | $2.8M of $4.3MAmount sold of the amount offered on the filing of 2026-07-16 · as of 2026-10-04How this is computed → | 2026-07-16 | San Diego, CA | 506(b) | 1The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Lynch Regenerative MedicineQuiet$15.0M of $17.5M · Series A · Health & bio · 506(b) · Franklin, TN · 2026-07-15 | Lynch Regenerative Medicine | Health & bio | Series A | $15.0M of $17.5MAmount sold of the amount offered on the filing of 2026-07-15 · as of 2026-10-04How this is computed → | 2026-07-15 | Franklin, TN | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| ImmunoVecHiring actively$12.7M of $15.0M · Series A · Health & bio · 506(b) · Los Angeles, CA · 2026-07-14 | ImmunoVec | Health & bio | Series A | $12.7M of $15.0MAmount sold of the amount offered on the filing of 2026-07-14 · as of 2026-10-04How this is computed → | 2026-07-14 | Los Angeles, CA | 506(b) | 3The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Neurofold Therapeutics Inc.Quiet$6.5M of $6.5M · Series A · Health & bio · 506(b) · Greenwood Village, CO · 2026-07-14 | Neurofold Therapeutics Inc. | Health & bio | Series A | $6.5M of $6.5MAmount sold of the amount offered on the filing of 2026-07-14 · as of 2026-10-04How this is computed → | 2026-07-14 | Greenwood Village, CO | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| CeleCor TherapeuticsQuiet$11.9M of $15.0M · Series A · Health & bio · 506(b) · Del Mar, CA · 2026-07-09 | CeleCor Therapeutics | Health & bio | Series A | $11.9M of $15.0MAmount sold of the amount offered on the filing of 2026-07-09 · as of 2026-10-04How this is computed → | 2026-07-09 | Del Mar, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| AmlogenyxQuiet$10.0M of $20.0M · Series A · Health & bio · 506(b) · Novato, CA · 2026-07-09 | Amlogenyx | Health & bio | Series A | $10.0M of $20.0MAmount sold of the amount offered on the filing of 2026-07-09 · as of 2026-10-04How this is computed → | 2026-07-09 | Novato, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet |